热门资讯> 正文
Clover Health预计2026年收入高于预期
2026-02-27 05:49
- Clover Health Investments (CLOV) is projecting 2026 revenue of $2.81B-$2.92B, above the consensus estimate of $2.74B.
- This year, the company also sees Medicare Advantage membership of 154,000-158,000. That's ~46% year-over-year growth at the midpoint.
- On a GAAP basis, Clover Health is eyeing a potential profit in 2026. GAAP net income is seen at $0-$20M.
- In Q4, Clover Health beat on the top line but missed on the bottom.
- In the quarter, its net loss widened to ($0.10) from ($0.04) in the year-ago period.
- Clover Health was hurt in the period by a ~50% year-over-year increase in total operating costs to $537M.
- The company ended 2025 with cash, cash equivalents, and investments of $319.9M compared to $437.6M on Dec. 31, 2024.
- Shares are up ~5% in after-hours trading Thursday.
More on Clover Health
- Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout
- Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Clover Health GAAP EPS of -$0.10 in-line, revenue of $487.7M beats by $20.64M
- SA analyst upgrades/downgrades: TSLA, UNH, CLOV, KMB
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。